Express News | Boai NKY Medical's invested company Yongtai Biotech products received breakthrough therapy designation from CDE.

BreakingsDec 11 11:24

Boai nky medical (300109.SZ): The company currently has a polymerization capacity of 0.034 million tons of nvp and 0.02 million tons of pvp.

On November 28, Gelonghui reported that boai nky medical (300109.SZ) stated on the investor interaction platform that the company currently has an aggregation capacity of 0.034 million tons of NVP and 0.02 million tons of PVP. In the future, the company will adjust the NVP monomer capacity and PVP aggregation capacity in a timely manner based on market sales and the expansion of product applications.

Gelonghui FinanceNov 28 14:41

Boai nky medical (300109.SZ): The company's products can be used in solid state batteries.

According to Boai Nky Medical (300109.SZ) on the investor interaction platform, the company's products can be used in solid state batteries.

Gelonghui FinanceNov 20 15:51

New Open Source: 2024 Q3 Report

SZSIOct 23 00:00 · Announcements

Boai Nky Medical (300109.SZ) released its performance for the first three quarters, with a net income of 0.311 billion yuan, a year-on-year decrease of 23.13%.

Boai nky medical (300109.SZ) disclosed the third quarter report of 2024, with the company achieving revenue of 11....

Zhitong FinanceOct 22 16:01

Boai Nky Medical (300109.SZ): The net income in the third quarter was 98.3134 million yuan, a 31.11% year-on-year decrease.

On October 22, Geelong released its third quarter report for 2024. In the third quarter of 2024, the company achieved revenue of 0.376 billion yuan, a decrease of 12.00% year-on-year; net income attributable to the company's shareholders was 98.3134 million yuan, a decrease of 31.11% year-on-year; net income after excluding non-recurring gains and losses was 0.104 billion yuan, a decrease of 27.73% year-on-year; basic earnings per share were 0.20 yuan per share.

Gelonghui FinanceOct 22 16:01